CTD Holdings Inc. (CTDH) news stock charts
CTD Holdings Inc. (CTDH/CTDH.OB) Investment Summary:
CTD Holdings, Inc. engages in the marketing and sale of cyclodextrins and related products. The company develops cyclodextrins-based applications in stabilization of flavors for food products; preparation of antifungal complexes for foods and toiletries; elimination of undesirable tastes and odors; stabilization of fragrances and dyes; reduction of foaming in foods; cosmetics and toiletries; and the improvement of quality, stability, and storability of foods. It also manufactures selected cyclodextrin complexes, as well as distributes cyclodextrins. CTD Holdings sell cyclodextrins, the molecules that bring oil and water together for applications in the areas of agriculture, analytical chemis...www.cyclodex.com
3 Employees
Founded in 1990
CTD HOLDINGS INC (CTDH:OTC Bulletin Board Market)
LAST $0.24 USD
CHANGE TODAY +0.065 38.24%
VOLUME 52.9K
As of 8:10 PM 03/19/10 All times are local (Market data is delayed by at least 15 minutes).
Snapshot of CTD HOLDINGS INC (CTDH)
|
OPEN
$0.17
|
PREVIOUS CLOSE
$0.17
|
|
|
DAY HIGH
$0.24
|
DAY LOW
$0.16
|
|
|
52 WEEK HIGH
03/19/10 - $0.24
|
52 WEEK LOW
03/23/09 - $0.02
|
|
|
MARKET CAP
6.7M
|
AVERAGE VOLUME 10 D
101.9K
|
|
|
EPS TTM
$-0.01
|
SHARES OUTSTANDING
28.6M
|
|
|
CTDH Does Not Pay Dividends
|
P/E TTM
--
|
|
| K = Thousands M = Millions B = Billions | ||
Key developments for CTD HOLDINGS INC (CTDH)
CTD Holdings Inc. Reorganizes Structure to Better Emphasize Branded Products, Trappsol(R) and Aquaplex(R)
03/8/2010
CTD Holdings Inc. announced its plans to move the company's Aquaplex(R) product line out of the CTD Inc. division and into NanoSonic Products Inc. (NSP). The decision was made as a result of a successful orphan drug application filing made to the U.S. Food and Drug Administration for Trappsol(R) Cyclo(TM) (hydroxypropyl beta cyclodextrin) in the treatment of Niemann Pick Type C disease. Niemann Pick Type C disease is a rare, fatal illness caused by a genetic mutation, which prevents cholesterol and other lipids from properly metabolizing within the cell. As a result, dangerous amounts of cholesterol accumulate in the liver and spleen and ultimately the brain. Although rare, Niemann Pick Type C disease has generated enormous medical interest because a specific gene can now be associated with cholesterol homeostasis at the cellular level. In animal studies, parenteral use of Trappsol(R) Cyclo(TM) has been shown to restore cholesterol homeostasis in certain somatic and brain cells.
CTD Holdings Inc. Signs Letter of Intent with J. Jireh Holdings, LLC to Form Joint Venture ; Announces Executive Appointment to the Joint Venture
12/22/2009
CTD Holdings Inc. announced that the company has entered into a Letter of Intent to form a joint venture with J. Jireh Holdings, LLC. Under the agreement CTD Holdings will contribute cash and other assets to a joint venture (JV) with J. Jireh which will contribute know how and other assets. The JV will develop and manufacture proprietary cyclodextrin complexes and branded products utilizing joint intellectual contributions and the pulse combustion dryer purchased by the JV. The physical plant is located and operating in Payson, Arizona. Jeffrey Tate PhD, will join the JV as Chief Operating Officer and President. Mr. Strattan will be the Chief Executive Officer of the JV.
CTD Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2009
11/18/2009
CTD Holdings Inc. reported earnings results for the third quarter and nine months ended September 30, 2009. For the quarter, the company posted net income of $32,735. Revenue increased 51.5% against September 30, 2008 period. For the nine months, loss was $34,871 against $74,606 a year ago. Overall revenue increased 24% to $460,277 against $371,230 for the comparable 2008 period.
CTD Holdings Inc. financial resources
CTDH Competitors
| Company | Last | Change | |
| No competitor information is available for CTDH. | |||
| Market data is delayed at least 15 minutes. | |||
Industry Analysis
| Valuation | CTDH | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 11.7x |
|
| Price/Book | 5.4x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 11.1x |
|
|
CTDH |
||
|
CTDH transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent Financial News About CTD Holdings Inc.
CTD Holdings, Inc. Formalizes International Sales of Trappsol(R) Cyclo(TM) for Treatment of Niemann-Pick Type C (NPC)
2010-03-15 08:15:55
Quote: CTDHNewsCDJNewsLebanonJapan. "We are monitoring the results of these interventions and continue to supply larger amounts of Cyclo™ to the requesting medical facilities as they implement the AddiandCassi protocol," stated CEO, Rick Strattan. He continued, "The Company expects significant growth in its international sales of the Cyclo™ product line in 2010."www.Addiandcassi.com) had their orphan drug application accepted by the US FDA for Trappsol® Cyclo™ to treat NPC.NPC is o...Read article
CTD Holdings, Inc. Reorganizes Structure to Better Emphasize Branded Products, Trappsol(R) and Aquaplex(R)
2010-03-10 01:24:24
Quote: CTDHNewsCDJNewsU.S. Food and Drug Administration for Trappsol® Cyclo™ (hydroxypropyl beta cyclodextrin) in the treatment of Niemann Pick Type C disease.Niemann Pick Type C disease is a rare, fatal illness caused by a genetic mutation, which prevents cholesterol and other lipids from properly metabolizing within the cell. As a result, dangerous amounts of cholesterol accumulate in the liver and spleen and ultimately the brain. Although rare, Niemann Pick Type C disease has generated enor...Read article
CTD Holdings, Inc. Reorganizes Structure to Better Emphasize Branded Products, Trappsol(R) and Aquaplex(R)
2010-03-09 08:45:07
Quote: CTDHNewsCDJNewsU.S. Food and Drug Administration for Trappsol® Cyclo™ (hydroxypropyl beta cyclodextrin) in the treatment of Niemann Pick Type C disease.Niemann Pick Type C disease is a rare, fatal illness caused by a genetic mutation, which prevents cholesterol and other lipids from properly metabolizing within the cell. As a result, dangerous amounts of cholesterol accumulate in the liver and spleen and ultimately the brain. Although rare, Niemann Pick Type C disease has generated enor...Read article
CTD Holdings, Inc. Names President of Newly Formed Subsidiary
2010-03-01 04:19:27
Quote: CTDHNewsCDJNews) announces the installation of Dr. Jeffrey Tate as the President/COO of NanoSonic Products, Inc. ("NSP"), a new, wholly owned subsidiary.Dr. Tate, former President of J. Jireh Products, LLC, has begun planning for the company's acquisition of a new Pulse Dryer system to be installed at CTD's 40 acre facility in High Springs, Florida. "Dr. Tate has 18 years of experience with the development of products surrounding the utilization of Pulse Drying technologies," stated CEO and Chai...Read article
CTD Holdings, Inc. Names President of Newly Formed Subsidiary
2010-02-18 06:11:11
Quote: CTDHNewsCDJNews) announces the installation of Dr. Jeffrey Tate as the President/COO of NanoSonic Products, Inc. ("NSP"), a new, wholly owned subsidiary.Dr. Tate, former President of J. Jireh Products, LLC, has begun planning for the company's acquisition of a new Pulse Dryer system to be installed at CTD's 40 acre facility in High Springs, Florida. "Dr. Tate has 18 years of experience with the development of products surrounding the utilization of Pulse Drying technologies," stated CEO and Chai...Read article
CTD Holdings Announces Second Quarter Results
2010-01-29 01:34:57
Quote: CTDHNewsCDJNews) announced today its second quarter results of operations.Net Operating Loss decreased 36.7% and product sales increased 6.9% to
almost $245,000 for the first six months of 2009 compared to the same
period in 2008."Although profit and loss have not been emphasized by management in the
past because the dollar amounts were always small, it's nice to see both
going in the right direction. Third quarter sales have gotten off to a
great start already," stated Rick Strattan, Chairman/C...Read article
CTD Holdings, Inc. Announces Profitable 3rd Quarter Results
2010-01-29 01:34:56
Quote: CTDHNewsCDJNews) announced today its third quarter results of operations.CTD Holdings posted net income for the third quarter of $32,735 and reduced
its total nine month loss to ($34,871) vs. ($74,606) in 2008, a 53.3%
improvement. Revenue increased 51.5% for the three months ended September
30, 2009 vs. the September 30, 2008 period. Overall revenue for the nine
months ended September 30, 2009 increased 24% to $460,277 vs. $371,230 for
the comparable 2008 period. Working capital increased 21.4%...Read article
ViStra Growth Partners to Begin Accepting Clients
2010-01-29 01:34:56
Quote: CTDHNewsCDJNews) announced today that ViStra Growth Partners, Inc., a
wholly owned subsidiary of CTD Holdings, Inc., will begin accepting
clients.ViStra is a consulting company providing corporate planning and strategic
growth strategies for private, start-up and micro-cap public companies.
ViStra provides its clients with consulting services relating to business
structure, organizational management, capital procurement, accessing public
capital markets, strategic acquisitions and investor commu...Read article
CTD Holdings, Inc. Signs Letter of Intent With J. Jireh Holdings, LLC
2010-01-29 01:34:55
Quote: CTDHNewsCDJNews) announced today that the Company has entered into a Letter
of Intent to form a Joint Venture with J. Jireh Holdings, LLC.Under the agreement CTD Holdings will contribute cash and other assets to a
joint venture (JV) with J. Jireh which will contribute know how and other
assets. The JV will develop and manufacture proprietary cyclodextrin
complexes and branded products utilizing joint intellectual contributions
and the pulse combustion dryer purchased by the JV. The physical plan...Read article
ViStra Growth Partners, Inc. Signs Agreement to Consult Aventura Equities, Inc.
2010-01-29 01:34:55
Quote: CTDHNewsCDJNewsAVNENews).Under the agreement ViStra will receive restricted shares of common stock
of Aventura and provide consulting services relating to corporate
development initiatives, including prospective acquisitions and corporate
structuring scenarios.Frank Manzo, III, Chief Executive Officer of Aventura, commented, "After
two years of reorganizing and cleaning up issues left by previous
management, the Company is now positioned to expand its food and beverage
distribution business and ...Read article
ViStra Growth Partners, Inc. Signs Consulting Agreement With Coastal Capital Acquisition Corporation ("Coastal")
2010-01-21 01:28:33
Quote: CTDHNewsCDJNewsCCAJNews).Under the agreement, ViStra will receive restricted shares of common stock
of Coastal and provide consulting services relating to corporate
development initiatives, including prospective acquisitions and corporate
structuring scenarios.Tracy Anderson, Chief Executive Officer of Coastal, commented, "Coastal has
come to a crossroads where experience in the acquisition of strategic
assets will assist the Company in affecting our plans to become focused in
the alternative en...Read article
ViStra Growth Partners, Inc. Signs Agreement to Consult Aventura Equities, Inc.
2009-12-23 01:27:36
Quote: CTDHNewsCDJNewsAVNENews).Under the agreement ViStra will receive restricted shares of common stock
of Aventura and provide consulting services relating to corporate
development initiatives, including prospective acquisitions and corporate
structuring scenarios.Frank Manzo, III, Chief Executive Officer of Aventura, commented, "After
two years of reorganizing and cleaning up issues left by previous
management, the Company is now positioned to expand its food and beverage
distribution business and ...Read article
CTD Holdings, Inc. Signs Letter of Intent With J. Jireh Holdings, LLC
2009-12-23 01:27:35
Quote: CTDHNewsCDJNews) announced today that the Company has entered into a Letter
of Intent to form a Joint Venture with J. Jireh Holdings, LLC.Under the agreement CTD Holdings will contribute cash and other assets to a
joint venture (JV) with J. Jireh which will contribute know how and other
assets. The JV will develop and manufacture proprietary cyclodextrin
complexes and branded products utilizing joint intellectual contributions
and the pulse combustion dryer purchased by the JV. The physical plan...Read article
CTD HOLDINGS INC Files SEC form 10-Q, Quarterly Report
2009-11-30 05:08:27
Quote: Management's Discussion and Analysis or Plan of Operation.
Introduction
CTD Holdings,Inc.(referred to as the "Company," "CTD" or in the first person
notations of "we," "us," and "our") beganoperations in 1990.Our revenues are
principallyderivedfromretailsalesofcyclodextrinsandcyclodextrin
complexes.Our sales are primarily to majorchemicalsupply houses around the
world, pharmaceutical companies, and food companies for research and development
a...Read article
CTD HOLDINGS INC Files SEC form 10-Q, Quarterly Report
2009-11-30 05:08:26
Quote: Management's Discussion and Analysis or Plan of Operation.
Introduction
CTD Holdings,Inc.(referred to as the "Company," "CTD" or in the first person
notations of "we," "us," and "our") beganoperations in 1990.Our revenues are
principallyderivedfromretailsalesofcyclodextrinsandcyclodextrin
complexes.Our sales are primarily to majorchemicalsupply houses around the
world, pharmaceutical companies, and food companies for research and development
a...Read article
CTD Holdings Announces Second Quarter Results
2009-11-30 05:08:26
Quote: CTDHNewsCDJNews) announced today its second quarter results of operations.Net Operating Loss decreased 36.7% and product sales increased 6.9% to
almost $245,000 for the first six months of 2009 compared to the same
period in 2008."Although profit and loss have not been emphasized by management in the
past because the dollar amounts were always small, it's nice to see both
going in the right direction. Third quarter sales have gotten off to a
great start already," stated Rick Strattan, Chairman/C...Read article
CTD HOLDINGS INC Files SEC form 10-Q, Quarterly Report
2009-11-30 05:08:26
Quote: Management's Discussion and Analysis or Plan of Operation.
Introduction
CTD Holdings,Inc.(referred to as the "Company," "CTD" or in the first person
notations of "we," "us," and "our") beganoperations in 1990.Our revenues are
principallyderivedfromretailsalesofcyclodextrinsandcyclodextrin
complexes.Our sales are primarily to majorchemicalsupply houses around the
world, pharmaceutical companies, and food companies for research and development
a...Read article
CTD Holdings, Inc. Announces Profitable 3rd Quarter Results
2009-11-30 05:08:25
Quote: CTDHNewsCDJNews) announced today its third quarter results of operations.CTD Holdings posted net income for the third quarter of $32,735 and reduced
its total nine month loss to ($34,871) vs. ($74,606) in 2008, a 53.3%
improvement. Revenue increased 51.5% for the three months ended September
30, 2009 vs. the September 30, 2008 period. Overall revenue for the nine
months ended September 30, 2009 increased 24% to $460,277 vs. $371,230 for
the comparable 2008 period. Working capital increased 21.4%...Read article
ViStra Growth Partners to Begin Accepting Clients
2009-11-30 05:08:25
Quote: CTDHNewsCDJNews) announced today that ViStra Growth Partners, Inc., a
wholly owned subsidiary of CTD Holdings, Inc., will begin accepting
clients.ViStra is a consulting company providing corporate planning and strategic
growth strategies for private, start-up and micro-cap public companies.
ViStra provides its clients with consulting services relating to business
structure, organizational management, capital procurement, accessing public
capital markets, strategic acquisitions and investor commu...Read article
Would you like to leave a comment about CTD Holdings Inc. CTDH/CTDH.OB
Find out what social network information about CTD Holdings Inc. are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides CTD Holdings Inc.'s Stock there is more great penny stock and market information at Realpennies